
Recursion Publishing Announces The Release Of Dr. Steven J. Hatfill's Latest Book
In his new book Unmasked, Dr. Hatfill identifies the weaknesses of America's response plan and the resulting loss of public trust. This book is a demand for accountability.
"The time for silence is over," writes Dr. Hatfill.
Dr. Hatfill has extensive experience in infectious disease control, disaster preparedness, and toxicology. He holds medical fellowships from several institutions, including Oxford University and NIH. In 2020, Dr. Hatfill was called to serve as a medical and scientific advisor in the Executive Office of the President. In 2025, he returned to the capital as Senior Adviser to the Secretary of Health and Human Services (HHS).
Visit: drstevenhatfill
Please direct all media inquiries to RECURSION MEDIA GROUP, INC. at 352.282.0778, [email protected] , or visit recursionmediagroup.
Available on Amazon and Barnes & Noble
Recursion Media Group, Inc. (RMG) owns and operates Recursion Publishing, RMG Innovations, Recursion Live, and RMG News Daily. For more information, please visit recursionmediagroup or contact RMG @ 352.282.0778
SOURCE Recursion Publishing

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- B2BROKER Launches First-Ever Turnkey Liquidity Provider Solution
- Amboss Launches Rails: Empowering Bitcoin Yield And Lightning Network Growth
- B2PRIME Appoints Former Onezero Sales Head Stuart Brock As Institutional Business Development Manager
- My Funding Account Builds A Global Trader Community On Trust, Transparency, And Growth
- Young Entrepreneur Rayston Heem Launches Mentorship Program After Early Business Milestone
- Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
Comments
No comment